Researchers Submit Patent Application, 'Pharmaceutical Compositions And Combinations Comprising Inhibitors Of The Androgen Receptor And Uses Thereof', for Approval (USPTO 20240261282)

Source :: Obesity, Fitness & Wellness Week. August 31, 2024, 1391
Publication Year :: 2024
Abstract: 2024 AUG 31 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- From Washington, D.C., NewsRx journalists report that a patent application by the [...]

Subjects :: Steroids -- Physiological aspects
Phenylbutazone -- Physiological aspects -- Intellectual property
Nilotinib -- Physiological aspects
Antineoplastic agents -- Physiological aspects -- Intellectual property
Antiviral agents -- Physiological aspects
Fluocinolone acetonide -- Physiological aspects
Anti-HIV agents -- Physiological aspects
Fluocinolone -- Physiological aspects
Physical fitness -- Physiological aspects
Antimitotic agents -- Physiological aspects -- Intellectual property
Tixocortol -- Physiological aspects
Darunavir -- Physiological aspects
Androgens -- Physiological aspects
Atazanavir -- Physiological aspects -- Intellectual property
Health

Tools